Planning cocaine treatment in Europe from the United States requires coordination before departure and after the return. The residential or hospital program is one part of the plan; the US assessment, travel arrangements, medication pathway, payment, and receiving clinicians also need attention.
Start by asking the current care team what a European service should provide that is difficult to obtain through suitable US options. A specific clinical reason makes the comparison more useful than a preference for a destination. This guide explains the planning sequence using official sources checked on October 18, 2026.
Define the treatment need before selecting a country
Arrange a current assessment of cocaine use, other substances, prescribed medicines, mental health, physical health, and previous treatment. Ask what level of care is appropriate and whether another medical or psychiatric service is needed before a planned residential stay.
Discuss realistic US alternatives at the same intensity. A weekly appointment and a residential program offer different amounts of support, so geography alone cannot explain the difference. SAMHSA describes the range of treatment settings and services available to consider. Source: SAMHSA treatment types.
Our European program comparison can help generate questions, but the final shortlist should follow the assessed needs. Ask each provider to explain its clinical capabilities, admission limits, and process for referring to another level of care when necessary.
Ask what the cocaine-focused work would involve
Request an explanation of how the program will examine recurring use, cravings, and the situations in which cocaine has become difficult to avoid. SAMHSA’s stimulant-treatment guidance discusses behavioral methods, engagement, and practical recovery skills. Ask which methods the team actually provides and how they would be selected for the person. Source: SAMHSA practical stimulant-treatment strategies.
For example, if use often follows work dinners or business travel, ask how the therapeutic work will connect with those situations after the return. A period away may change immediate access and routine, but the plan still needs to address the environment the person expects to reenter. The clinician can help identify what needs to be practiced or changed.
Ask how psychiatric concerns and other substance use will influence that work. If alcohol is often involved in a cocaine episode, the assessment should consider both patterns rather than build an isolated account of one drug. If anxiety, sleep problems, or low mood affect participation, identify the professional who will assess them.
Agree on review points and useful signs of progress. Attendance alone does not explain whether the person understands the plan or can apply it. Ask how the team will discuss engagement, functioning, remaining difficulties, and the practical next steps with the patient.
Build a US team that remains connected during the stay
Identify the clinician who knows the current history and can help review the overseas proposal. This may include an addiction clinician, psychiatrist, primary care professional, or several people with distinct roles. Ask who can communicate with the receiving program and what consent is required.
Tell those professionals why travel is being considered and what services the overseas program proposes. Invite questions about medicines, psychiatric symptoms, physical monitoring, and the plan after discharge. The purpose is to make the international episode part of ongoing care rather than a disconnected interval.
Confirm what each US clinician can and cannot provide while the person is abroad. Routine contact, record sharing, remote clinical treatment, and prescribing are different activities. Do not assume an existing relationship permits every service from every location; ask the clinician to confirm the arrangements for the actual destination.
Obtain a clinical admission decision before treating flights as fixed
Send the receiving team a current history and relevant records. Include changes since any earlier inquiry, particularly new medicines, other substance use, psychiatric symptoms, or physical health concerns. Ask who reviews the information and whether further assessment is needed before admission can be agreed.
Clarify any requirement for withdrawal management or stabilization first. If another service is involved, identify who coordinates it, who confirms readiness for transfer, and how the clinical record reaches the residential team. A reservation should not be treated as proof that every preceding medical need has been resolved.
Discuss the route and any support needed during transit with the relevant professionals. Ask whether the person can travel through the proposed connections and what would prompt reconsideration before departure. A transport booking or airport collection does not itself establish clinical supervision during the journey.
Prepare for the itinerary, including stopovers
CDC recommends an individualized pre-travel consultation that considers health history, destination, duration, purpose, and planned activities. Explain that the trip is for treatment so relevant health and practical questions can be addressed. Source: CDC pre-travel consultation guidance.
Check entry requirements for the person’s nationality, travel documents, destination, and intended length of stay through the relevant official authorities. Europe is not one medication or entry jurisdiction. A stopover or a later move to another country may create additional requirements to resolve.
Ask the provider what documentation it can supply to describe the planned stay when necessary. Keep administrative eligibility separate from clinical suitability. Meeting travel-document requirements does not answer whether the person is medically ready for the journey or appropriate for the program.
Review medicines in both directions
Prepare a complete list using generic names, formulations, actual regimens, and indications. Ask the destination’s relevant authority about lawful carriage, documentation, and supply. Include medicines used for psychiatric care and any controlled drug, not only products that seem directly related to cocaine treatment.
The return to the United States needs its own review if medicines are prescribed or dispensed abroad. FDA explains that foreign drug approval does not establish lawful US importation and distinguishes rules for US citizens from those for foreign nationals. Controlled substances also involve DEA requirements. Source: FDA personal importation guidance.
Do not assume a general quantity allowance or a foreign prescription resolves the individual case. Ask the relevant US authorities about the exact product and circumstances before the return. Discuss a lawful continuation plan with the US prescriber and pharmacist rather than leaving that question until the supply is nearly exhausted.
If a new medicine is proposed during treatment, ask how it will be continued and monitored at home. The overseas clinician should explain the recommendation and share relevant information; the receiving US clinician needs to assess and accept their own prescribing responsibilities.
Separate treatment funding from travel insurance
Ask the health insurer whether the named overseas service and level of care are covered, whether authorization is required, and what documentation is needed. Clarify separately billed clinicians, medicines, investigations, and the possibility of a transfer to another facility. A general international benefits statement is not a personal payment guarantee.
Travel insurance, medical coverage abroad, and medical evacuation cover have different purposes. The US State Department advises travelers to plan for overseas medical expenses and notes that the US government does not pay those costs. Source: State Department travel insurance guidance.
Read the policy’s treatment, preexisting-condition, psychiatric-emergency, and evacuation terms. CDC notes that psychiatric emergencies or preexisting conditions may be excluded from evacuation policies. Ask the insurer to explain the actual coverage relevant to the planned trip. Source: CDC mental health and travel guidance.
Compare costs across the whole episode
| Expense | Question for the budget |
|---|---|
| US preparation | Which assessments, records, or medical reviews are needed? |
| Overseas clinical care | What program, currency, duration, and professional contacts are included? |
| Additional services | How are medicines, tests, outside consultations, and transfers charged? |
| Travel | What happens financially if dates change or an escort is required? |
| Family participation | Are remote sessions or visits included, and who pays associated costs? |
| US continuation | Can the person fund therapy, prescribing, and practical support after returning? |
Confirm extension, cancellation, and early-departure terms before making a substantial payment. Keep the price unit clear: a residential week, a month, and a defined aftercare period are not interchangeable. Ask the provider to explain the clinical review process as well as the financial terms for any change.
Our cost guide helps compare quotations. Avoid using the entire available budget on residence if that would leave the agreed next phase inaccessible. Raise constraints early so the clinicians can discuss realistic alternatives.
Arrange English records and a receiving appointment
CDC’s medical-tourism guidance recommends obtaining overseas records in English and sharing them with professionals providing follow-up. For cocaine treatment, ask for a useful clinical summary explaining the assessment, treatment completed, medication decisions, remaining questions, and next steps. Source: CDC medical-tourism planning guidance.
Identify the US clinician who will receive that information before discharge. Confirm the first appointments, medication supply, required tests, and the route to reassessment if needs increase. A written recommendation is valuable, but it does not establish that another clinician has accepted the role.
Discuss time zones, language, privacy, and family involvement during the stay. Ask which overseas follow-up services remain available after the person returns to their US state and what each contact provides. Coordination, psychotherapy, prescribing, and peer support should be described separately.
The international plan is strongest when the reason for traveling and the return-home arrangements are equally specific. The person should know what the European program is expected to add, how clinical responsibilities are shared, and who will help translate that work into everyday life in the United States.
Sources and further reading
Found a detail that has changed? Tell the editorial team.